This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Colorado. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2012
Title: Tania Azam: Pioneering Innovations in Immunotherapy
Introduction
Tania Azam, an accomplished inventor based in Denver, Colorado, has made significant strides in the field of immunotherapy. With a focus on addressing critical health challenges, her innovations highlight the intersection of science and medicine, providing hope for the treatment of autoimmune diseases and cancer.
Latest Patents
Tania Azam holds two notable patents that focus on the regulation of tumor necrosis factor-alpha (TNF-α). The first patent outlines compositions and methods related to an interleukin 18-inducible cytokine known as tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). This groundbreaking invention aims to develop treatments for autoimmune diseases and cancer by regulating TNF-α expression.
Her second patent elaborates on similar themes, providing compositions comprising a nucleic acid encoding TAIF or IL-32. This invention introduces vectors for expressing proteins that are crucial in the fight against autoimmune conditions and cancer, further emphasizing the potential of manipulating TNF-α expression for therapeutic purposes.
Career Highlights
Tania works at the University of Colorado, where she dedicates her efforts to advancing research in immunotherapy. Her work has contributed to a deeper understanding of cytokines and their roles in immune response regulation, positioning her as a key figure in her field.
Collaborations
Throughout her career, Tania Azam has collaborated with esteemed colleagues such as Soo-Hyun Kim and Charles A. Dinarello. These partnerships have facilitated the exchange of ideas and expertise, driving innovation in the study of cytokines and therapeutic interventions for serious health conditions.
Conclusion
Tania Azam’s contributions through her patents and collaborative efforts reflect her commitment to improving medical treatments for autoimmune diseases and cancer. As a pioneering inventor, her innovations continue to inspire advancements in immunotherapy, shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile